Table 3 Comparison of clinical indices, histopathologic factors and imaging indices between neoadjuvant therapy followed by radical hysterectomy group and concurrent chemoradiotherapy group
Index | NAT + RH group (n = 86) | CCRT group (n = 63) | p value |
|---|---|---|---|
Age | 50.3 ± 8.7 | 51.9 ± 8.0 | 0.244 |
FIGO | 0.683 | ||
IB2 | 37 | 25 | |
IIA2 | 49 | 38 | |
Pretreatment hemoglobin | 0.537 | ||
Normal | 66 | 51 | |
Abnormal | 20 | 12 | |
SCC-Ag | 3.1 (1.7, 6.0) | 4.9 (1.8, 10.9) | 0.099 |
MDT | 45.0 (42.0, 50.0) | 44.0 (41.0, 48.0) | 0.277 |
ADCmax | 1.080 ± 0.132 | 1.053 ± 0.117 | 0.205 |
ADCmean | 0.908 ± 0.133 | 0.886 ± 0.117 | 0.296 |
ADCmin | 0.769 ± 0.115 | 0.752 ± 0.117 | 0.379 |
LNM | 0.053 | ||
Positive | 19 | 23 | |
Negative | 67 | 40 |